How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Preparedness and Response Considerations for High-Consequence Infectious Disease – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – The Pockmarked Face of the Comte de Mirabeau – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Molecular Characterization of Echinococcus vogeli from Human Case, Colombia, 2024 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Henipavirus in Northern Short-Tailed Shrew, Alabama, USA – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Seroprevalence of Rift Valley and Crimean-Congo Hemorrhagic Fever Viruses, Benin, 2022–2023 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Emergence of Novel Fluoroquinolone Resistance Mutations in Mycoplasma bovis, China, 2008–2023 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Complete Genome Analysis of African Swine Fever Virus Isolated from Wild Boar, India, 2021 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Communicable disease threats report, 5-11 July 2025, week 28

Early Release – Neurologic Manifestations Associated with Parvovirus B19 Epidemic, Madrid, Spain, 2024 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us